Medicine company Novartis (NVS) said on Thursday that a late-stage trial evaluating its drug Cosentyx in adults with newly diagnosed or relapsing giant cell arteritis failed to meet its primary goal ...
15don MSN
Common diabetes drug fails to improve walking performance in peripheral artery disease patients
A common diabetes medication does not help people with peripheral artery disease (PAD) and without diabetes walk farther, ...
Drug maker Novo Nordisk says semaglutide, the active ingredient for the weight loss jab Wegovy, does not slow Alzheimer's - despite initial hopes that it might help against dementia. Researchers began ...
Dec 11 (Reuters) - Rezolute said on Thursday its experimental drug for a rare condition that causes dangerously low blood sugar failed to meet the main goal in a late-stage study. (Reporting by ...
TRENTON, N.J. (AP) -- A closely watched experimental Alzheimer's treatment has failed to slow the disease in one late-stage study, a big disappointment for doctors and patients but not the end of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results